Torrent Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1847.5
- Today's High:
- ₹1885.75
- Open Price:
- ₹1865.25
- 52W Low:
- ₹1429.9111
- 52W High:
- ₹2099.95
- Prev. Close:
- ₹1867.8
- Volume:
- 7652
Company Statistics
- Market Cap.:
- ₹387.72 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Torrent Pharmaceuticals Limited had its IPO on under the ticker symbol 500420.
The company operates in the Healthcare sector and Pharmaceuticals industry. Torrent Pharmaceuticals Limited has a staff strength of 12,562 employees.
Stock update
Shares of Torrent Pharmaceuticals Limited opened at ₹1865.25 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1847.5 - ₹1885.75, and closed at ₹1857.35.
This is a -0.56% slip from the previous day's closing price.
A total volume of 7,652 shares were traded at the close of the day’s session.
In the last one week, shares of Torrent Pharmaceuticals Limited have increased by +1.58%.
Torrent Pharmaceuticals Limited's Key Ratios
Torrent Pharmaceuticals Limited has a market cap of ₹387.72 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Torrent Pharmaceuticals Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Torrent Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Torrent Pharmaceuticals Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Torrent Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Torrent Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Torrent Pharmaceuticals Limited’s profitability.
Torrent Pharmaceuticals Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Torrent Pharmaceuticals Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹150.12 billion
- Total Liabilities
- ₹54.47 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Torrent Pharmaceuticals Limited ended 2024 with ₹150.12 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹150.12 billion while shareholder equity stood at ₹61.98 billion.
Torrent Pharmaceuticals Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹54.47 billion in other current liabilities, 1692300000.00 in common stock, ₹60.29 billion in retained earnings and ₹3.38 billion in goodwill. Its cash balance stood at ₹5.08 billion and cash and short-term investments were ₹8.36 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹24.96 billion.
Torrent Pharmaceuticals Limited’s total current assets stands at ₹53.29 billion while long-term investments were ₹0 and short-term investments were ₹2.65 billion. Its net receivables were ₹19.44 billion compared to accounts payable of ₹16.79 billion and inventory worth ₹22.30 billion.
In 2024, Torrent Pharmaceuticals Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Torrent Pharmaceuticals Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1857.35
- 52-Week High
- ₹2099.95
- 52-Week Low
- ₹1429.9111
- Analyst Target Price
- ₹
Torrent Pharmaceuticals Limited stock is currently trading at ₹1857.35 per share. It touched a 52-week high of ₹2099.95 and a 52-week low of ₹2099.95. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1945.48 and 200-day moving average was ₹1691.78 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Torrent Pharmaceuticals Limited
Similar Industry Stocks (Pharmaceuticals)
Most Active
Top Gainers
Top Losers
About
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology, pediatric, wound care, and nutraceuticals. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Private Limited.